Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes
ImportanceRisk factors for atherosclerotic cardiovascular disease (ASCVD) are well established in type 2 diabetes (T2D), but not in type 1 diabetes (T1D). The impact of partial clinical remission (PR) on short-term ASCVD risk in T1D is unclear.AimTo investigate the impact of PR on the earliest ASCVD...
Guardado en:
Autores principales: | Benjamin Udoka Nwosu, Sadichchha Parajuli, Krish Khatri, Gabrielle Jasmin, Layana Al-Halbouni, Austin F. Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/31ba85162293457e91654a534717c767 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
por: Hua-Xing Huang, et al.
Publicado: (2021) -
Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study
por: Rikke Viggers, et al.
Publicado: (2021) -
Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review
por: Hwi Seung Kim, et al.
Publicado: (2021) -
Prevalence of Overweight and Obesity in Type 2 Diabetic Patients Visiting PHC in the Dubai Health Authority
por: Noorah Bawady, et al.
Publicado: (2021) -
Diabetes Epidemiology and Management
Publicado: (2021)